Health Condition 1: G439- Migraine, unspecified
Conditions
Interventions
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
counselling for reduction of stress, depression and anxiety, postural corrections, reducing caffeine overuse, and daily supplementation of riboflavin 400 mg/day. Duration of therapy: 3 months.
Control
dosage and repetition depending upon the individual requirement of the cases. Each patients will be given general advices on lifestyle management by controlling trigger factors, like maintaining regul
counselling for reduction of stress, depression and anxiety, postural co
Sponsors
The Calcutta Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering from chronic migraine, that is, headache on 15 or more days/month for more than 3 months, with a feature of migraine headache on at least 8 days/month (ICD-10-CM Code G43.709) 2. Patients of 18-65 years of age and of either sex 3. Patients who have not taken any treatment since at least 2 weeks for migraine 4. Literate patients; can read Bengali and/or English 5. Providing written informed consent to participate in the trial
Exclusion criteria
Exclusion criteria: 1. Patients suffering from the complications of migraine 2. Patients who are undergoing treatment with non-steroidal anti-inflammatory drugs (NSAIDs), antiemetic, or oestrogen during 2 weeks prior to enrolment in the study 3. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life 4. Patients who are too sick for consultation 5. Pregnant and puerperal women, and lactating mothers 6. Substance abuse and/or dependence 7. Self-reported immune-compromised state 8. Undergoing homoeopathic treatment for any chronic disease within last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Monthly migraine days (MMD)Timepoint: At baseline, every month, up to 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| EQ-5D-5L scoresTimepoint: At baseline, every month, up to 3 months;Migraine Disability Assessment Test (MIDAS) scoresTimepoint: At baseline, every month, up to 3 months | — |
Countries
India
Contacts
Public ContactProf Dr Rajat Chattopadhyay
The Calcutta Homoeopathic Medical College and Hospital
Outcome results
None listed